VanEck Associates
HCM icon

VanEck Associates’s HUTCHMED HCM Stock Holding History

VanEck Associates’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-669
Closed -$12K – 1390
2023
Q4 		$12K Sell
669
-665
-50% -$12.1K ﹤0.01% 1342
2023
Q3 		$23K Buy
1,334
+784
+143% +$11.2K ﹤0.01% 1332
2023
Q2 		$7K Hold
550
– – ﹤0.01% 1371
2023
Q1 		$7K Sell
550
-10
-2% -$164 ﹤0.01% 1376
2022
Q4 		$8K Buy
560
+226
+68% +$2.47K ﹤0.01% 1378
2022
Q3 		$3K Buy
334
+157
+89% +$1.98K ﹤0.01% 1366
2022
Q2 		$2K Buy
177
+96
+119% +$1.22K ﹤0.01% 1353
2022
Q1 		$2K Hold
81
– – ﹤0.01% 1356
2021
Q4 		$3K Hold
81
– – ﹤0.01% 1352
2021
Q3 		$3K Buy
81
+46
+131% +$1.81K ﹤0.01% 1278
2021
Q2 		$1K Buy
+35
New +$1.01K ﹤0.01% 1268

Other funds holding HCM

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

VanEck Associates's HCM Position: Q1 2024 in Review

VanEck Associates sold out of HUTCHMED (HCM) in Q1 2024, closing a stake of 669 shares — an estimated $12K sold.

VanEck Associates first reported a position in HCM in Q2 2021 and held it in 11 quarters. The position peaked at $23K in Q3 2023. 71 funds tracked by Wall St. Rank hold HCM as of Q1 2024.

  • VanEck Associates reported no remaining HUTCHMED position as of Q1 2024 after selling out during the quarter.
  • VanEck Associates sold 669 HUTCHMED shares in Q1 2024, an estimated $12K.
  • VanEck Associates first reported a position in HUTCHMED in Q2 2021 and held it in 11 quarters.
  • VanEck Associates's HUTCHMED position peaked at $23K in Q3 2023.
  • 71 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2024.

Based on VanEck Associates's 13F filing for Q1 2024, filed 30 Apr 2024.